Supplement Industry Bills
Learn More About Our Current Initiatives and Take Action
FDASLA Act of 2022
Description: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
Our Position: No